Systemic immune activation method using nucleic acid-lipid complexes
US6693086B1 · kind B1 · utility
85Cited by
15References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 1998 |
| Grant date | Feb 17, 2004 |
| Priority date | — |
| Expiry date | Jun 25, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, or an infectious disease. Also disclosed are therapeutic compositions useful in such a method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.